Fibractiv 105mg Tablet
By Fibractiv
Rx
10 Tablet in a Strip

Composition
Fenofibrate(105mg)

Manufacturer - Cogentrix Pharma
no.3/10, mmtc colony, nanganallur, chennai - 600061

Expires on or after
October, 2025

liver
It is important to note that Fibractiv 105mg Tablet is not recommended for individuals with liver disease. Patients with severe liver disease should avoid using this medication. It is advised to consult your doctor before considering the use of Fibractiv 105mg Tablet, especially if you have any liver issues. Please prioritize your liver health and seek appropriate medical advice regarding the use of this medication.

kidney
Fibractiv 105mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, and those with severe kidney issues should avoid using this medication. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Fibractiv 105mg Tablet. Consult your doctor when consuming alcohol with Fibractiv 105mg Tablet.

driving
When taking Fibractiv 105mg Tablet, it is generally considered safe to drive as it does not typically impact your driving abilities.

pregnancy
It is advised not to use Fibractiv 105mg Tablet during pregnancy as it may be unsafe. Limited human studies and animal research suggest potential harm to the developing baby. Consult your doctor for personalized advice.

breastfeeding
Fibractiv 105mg Tablet may not be safe to use while breastfeeding. Limited evidence shows it could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | PPAR alpha |
Therapeutic Class | - |
Action Class | PPAR alpha agonists (Fibrate) |
₹125
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025